For the quarter ending 2026-03-31, KROS has $312,293K in assets. $26,663K in debts. $281,497K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 281,497 | 287,415 | 693,472 | 690,215 |
| Accounts receivable | 400 | 3,567 | 3,492 | 15,816 |
| Prepaid expenses and other current assets | 6,530 | 22,202 | 22,343 | 26,777 |
| Current income tax receivable | 2,250 | 2,250 | - | - |
| Other long term assets | - | 0 | 0 | 0 |
| Total current assets | 290,677 | 315,434 | 719,307 | 732,808 |
| Operating lease right-of-use assets | 16,205 | 16,841 | 17,463 | 18,072 |
| Property and equipment, net | 3,962 | 4,297 | 4,564 | 4,836 |
| Restricted cash | 1,449 | 1,449 | 1,449 | 1,449 |
| Total assets | 312,293 | 338,021 | 742,783 | 757,165 |
| Deferred revenue | - | - | 155 | 925 |
| Current tax liability | - | - | 4,147 | 6,321 |
| Accounts payable | 1,493 | 1,967 | 2,298 | 5,267 |
| Current portion of operating lease liabilities | 2,501 | 2,408 | 2,318 | 2,230 |
| Accrued expenses and other current liabilities | 8,859 | 16,039 | 15,174 | 19,964 |
| Total current liabilities | 12,853 | 20,414 | 24,092 | 34,707 |
| Operating lease liabilities, net of current portion | 13,810 | 14,475 | 15,111 | 15,724 |
| Total liabilities | 26,663 | 34,889 | 39,203 | 50,431 |
| Common stock, par value of 0.0001 per share 200,000,000 shares authorized as of march31, 2026 and december31, 2025 40,859,597 shares issued and 19,732,837 shares outstanding as of march31, 2026 and 40,670,466 shares issued and 19,543,706 shares outstanding as of december31, 2025 | 4 | 4 | 4 | 4 |
| Treasury stock, at cost 21,126,760 shares as of march31, 2026 and december31, 2025 | 384,558 | 384,558 | - | - |
| Additional paid-in capital | 1,175,657 | 1,169,451 | 1,161,880 | 1,157,754 |
| Accumulated deficit | -505,473 | -481,765 | -458,304 | -451,024 |
| Total stockholders' equity | 285,630 | 303,132 | 703,580 | 706,734 |
| Total liabilities and stockholders' equity | 312,293 | 338,021 | 742,783 | 757,165 |
Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS)